Mesterolone 10mg (Proviron)

Mesterolone 10mg (Proviron) | iRoids Pharma

Mesterolone 10mg is an oral androgen containing 10mg of Mesterolone per tablet. At iRoids Pharma, we carry Mesterolone 10mg as part of our oral androgen and ancillary compound inventory for customers in markets where Mesterolone is legally available.

Mesterolone is the active compound in this preparation, widely recognized under the brand name Proviron. The 10mg tablet format represents the lowest per-tablet concentration of Mesterolone available in the iRoids Pharma catalog and consequently carries a specific significance that distinguishes it from the standard 25mg format that has historically dominated both clinical and non-prescription market discussions of this compound.

This page covers the pharmacology, clinical background, concentration-specific considerations, and health and legal context relevant to anyone researching the 10mg Mesterolone format at iRoids Pharma. It does not constitute medical advice, recommend steroid use, or provide dosage, cycle, or stacking guidance of any kind.

Product Specifications

The 10mg Format and What Distinguishes It

The 10mg concentration of Mesterolone represents the most precise and conservative per-tablet format available in the iRoids Pharma Mesterolone product range. Understanding what this specific concentration offers compared to the standard 25mg format requires examining both the pharmacological and practical implications of the lower per-tablet dose.

Historical Context of the 10mg Format

The 25mg tablet has historically been the standard pharmaceutical format for Mesterolone across the markets where it carried regulatory approval. However, lower concentration formats including 10mg tablets have appeared in various international markets over the course of Mesterolone’s production history. The 10mg format consequently has a documented presence in Mesterolone’s broader commercial history, albeit less prominent than the universally recognized 25mg standard.

The significance of the 10mg format becomes clearer when considering Mesterolone’s pharmacological characteristics. Because Mesterolone produces dose-dependent effects across its multiple mechanisms including SHBG binding, mild aromatase inhibition, and androgenic receptor activation, the ability to work with 10mg increments rather than 25mg increments provides meaningful precision in managing the total daily androgen and anti-estrogenic exposure from this compound.

Precision Dosing Advantage

The primary practical distinction between the 10mg and 25mg Mesterolone formats is dose precision. The 10mg format allows total daily Mesterolone exposure to be titrated in 10mg increments rather than 25mg increments. For anyone researching Mesterolone who wants to work with conservative starting concentrations or fine-tune their total daily androgen exposure with greater granularity, the 10mg format provides a precision advantage that the 25mg format cannot replicate without tablet splitting.

This precision consideration is particularly relevant given Mesterolone’s role as an ancillary compound in many performance community discussions. When a compound is being used primarily for ancillary purposes such as SHBG reduction and mild aromatase inhibition rather than as a primary anabolic agent, the ability to manage total daily exposure with fine-grained precision is a meaningful practical advantage.

Comparison With the 25mg Format

The 10mg format delivers 40 percent of the active compound per tablet compared to the standard 25mg format. Every dose-dependent pharmacological effect including SHBG binding activity, aromatase inhibitory effect, androgen receptor activation, and androgenic side effect profile is proportionally less pronounced per tablet at the 10mg concentration than at the 25mg format. For anyone researching the most conservative available entry point into Mesterolone’s pharmacological profile, the 10mg format consequently represents that entry point within the iRoids Pharma catalog.

What Is Mesterolone

Mesterolone is a synthetic androgen derived from Dihydrotestosterone. Schering developed it and introduced it to international markets under the Proviron brand name for the treatment of male hypogonadism, androgen deficiency, and male infertility across several markets where it received regulatory approval.

Structurally, Mesterolone is a modified form of DHT with a methyl group at the first carbon position. This methyl group improves oral bioavailability and reduces the rate of metabolic inactivation that makes unmodified DHT largely inactive when administered orally. Critically, this structural modification achieves oral activity without 17-alpha alkylation. The absence of 17-alpha alkylation is consequently the primary structural reason Mesterolone carries a fundamentally different hepatotoxicity profile from most other oral androgens discussed in performance communities.

As a DHT derivative, Mesterolone does not aromatize to estrogen. DHT-derived compounds are structurally incompatible with the aromatase enzyme and consequently cannot undergo the enzymatic conversion to estradiol that testosterone and many other anabolic steroids undergo. Furthermore, Mesterolone carries no meaningful affinity for progesterone receptors, which distinguishes it from progestogenic compounds where progesterone receptor activation is a primary side effect consideration.

How Mesterolone Works

Mesterolone interacts with biological systems through several distinct pharmacological mechanisms that collectively produce its characteristic profile. These mechanisms operate simultaneously and their combined effect is what drives Mesterolone’s specific discussion in both clinical and performance community contexts.

Androgen Receptor Binding

Mesterolone binds to androgen receptors throughout the body with an androgenic rating of 30 to 40 relative to testosterone’s baseline of 100. Its anabolic rating of 100 to 150 reflects moderate anabolic receptor binding activity. At the 10mg concentration, androgen receptor activation is proportionally less pronounced per tablet than at the 25mg format. The pharmacological consequences of this receptor binding at 10mg per tablet are consequently more subtle than at higher concentrations, which is consistent with the precision dosing rationale for this specific format.

SHBG Binding and Free Testosterone Elevation

Sex Hormone-Binding Globulin binds to testosterone and other androgens in circulation, rendering them biologically inactive by preventing receptor binding. Mesterolone carries strong affinity for SHBG and displaces testosterone from SHBG binding sites, increasing the fraction of circulating testosterone that is free and biologically active. At the 10mg concentration, this SHBG displacement effect is proportionally less pronounced per tablet than at the 25mg format. However, the mechanism itself remains pharmacologically active at any concentration of Mesterolone and consequently contributes to its ancillary profile even at the 10mg dose.

Mild Aromatase Inhibition

Mesterolone carries mild inhibitory activity against the aromatase enzyme. This mild inhibition reduces the rate of androgen-to-estrogen conversion in peripheral tissues. At the 10mg concentration, the aromatase inhibitory effect is proportionally less pronounced than at the 25mg format. The degree of inhibition at 10mg per tablet is consequently at the more conservative end of Mesterolone’s already mild aromatase inhibitory spectrum. This makes the 10mg format particularly relevant for anyone researching the most subtle available anti-estrogenic contribution from Mesterolone.

No Aromatization

Mesterolone does not aromatize to estrogen at any concentration. As a DHT derivative, its structural incompatibility with the aromatase enzyme means it cannot undergo enzymatic conversion to estradiol. Estrogenic side effects are consequently not part of Mesterolone’s direct pharmacological profile regardless of whether the 10mg or 25mg format is being considered.

Minimal HPG Axis Effects

At standard clinical doses, Mesterolone does not produce significant suppression of the hypothalamic-pituitary-gonadal axis. At the 10mg concentration, this HPG-neutral characteristic is even more reliably maintained than at higher doses because the androgenic exposure per tablet is more conservative. The absence of meaningful HPG suppression at the 10mg format consequently makes it one of the most HPG-neutral oral androgen options available in the iRoids Pharma catalog.

Clinical Background

Mesterolone carries a documented clinical history across multiple indications in international markets. This clinical background provides meaningful context for understanding its pharmacological profile at any concentration.

Male Hypogonadism Treatment

Mesterolone has been prescribed in several countries for the treatment of male hypogonadism. Its androgenic activity supports testosterone-dependent physiological functions in androgen-deficient men without the HPG suppression that most testosterone-based treatments produce. The clinical use of Mesterolone in hypogonadism consequently reflects a pharmacological role distinct from conventional testosterone replacement approaches and provides a meaningful clinical reference for its androgenic activity profile.

Male Infertility

Mesterolone has been studied and used clinically for male infertility treatment in several international markets. Research has examined its effects on sperm quality, count, and motility in men with specific fertility-related diagnoses. This represents one of the most pharmacologically distinctive clinical applications of any androgen discussed in performance communities. Most anabolic steroids are associated with suppressing rather than supporting male reproductive function. Mesterolone’s HPG-neutral profile consequently makes it uniquely relevant to fertility-related clinical discussions.

Androgen Deficiency and Mood Disorders

In addition to hypogonadism treatment, Mesterolone has been prescribed in several countries for broader androgen deficiency conditions and was historically used as an adjunctive treatment for depression in men in some European markets. These applications reflect the broader physiological role of androgen status in male health and provide additional clinical context for Mesterolone’s documented effects beyond its primary androgenic applications.

Mesterolone 10mg Versus Other Compounds at iRoids Pharma

Versus Mesterolone 25mg

Both formats contain the same active Mesterolone compound with identical pharmacological mechanisms. The 10mg format delivers 40 percent of the active compound per tablet compared to the 25mg format. Every dose-dependent pharmacological effect including SHBG binding, aromatase inhibition, androgen receptor activation, and androgenic side effects is proportionally less pronounced per tablet at the 10mg concentration. The 10mg format consequently provides greater dose precision and a more conservative per-tablet exposure than the 25mg format while operating through identical pharmacological mechanisms.

Versus Anastrozole

Anastrozole is a dedicated third-generation non-steroidal aromatase inhibitor producing approximately 70 to 80 percent estrogen suppression at standard clinical doses. Mesterolone at 10mg produces considerably milder aromatase inhibition while adding SHBG binding and androgenic activity that Anastrozole does not carry. These two compounds serve different primary pharmacological roles. Anastrozole is the appropriate choice when potent dedicated estrogen suppression is the primary goal. The 10mg Mesterolone format is more relevant when a subtle ancillary androgenic and anti-estrogenic contribution with high precision is the specific objective.

Versus Methandrostenolone 10mg

Methandrostenolone 10mg is a 17-alpha alkylated oral anabolic steroid with significant hepatotoxicity, strong aromatization to estrogen, and meaningful HPG suppression. Mesterolone 10mg is non-17-alpha alkylated with low hepatotoxicity, no aromatization, and minimal HPG suppression. These two compounds consequently represent fundamentally opposite pharmacological profiles despite both being 10mg oral tablets. Methandrostenolone 10mg is primarily anabolic with significant estrogenic and hepatotoxic considerations. Mesterolone 10mg is primarily androgenic and ancillary with minimal estrogenic and hepatotoxic considerations.

Versus Oxandrolone 10mg

Oxandrolone 10mg is a 17-alpha alkylated non-aromatizing oral anabolic steroid with mild to moderate liver toxicity and active FDA approval. Both Oxandrolone 10mg and Mesterolone 10mg are 10mg oral non-aromatizing compounds with comparatively mild side effect profiles. However, Oxandrolone carries significantly higher anabolic activity and more pronounced HPG suppression than Mesterolone. Furthermore, Oxandrolone’s 17-alpha alkylation produces a more significant hepatotoxicity consideration than Mesterolone’s non-alkylated structure. These distinctions place the two compounds in different pharmacological categories despite sharing the same tablet concentration and non-aromatizing characteristic.

Versus Testosterone Cypionate

Testosterone Cypionate is an injectable long-acting testosterone ester with strong androgenic and anabolic activity, significant aromatization to estrogen, and pronounced HPG suppression. Mesterolone 10mg, by contrast, produces moderate androgenic activity without aromatization and minimal HPG suppression while simultaneously increasing the free testosterone fraction through SHBG displacement. The contrasting profiles of these two compounds make Mesterolone 10mg pharmacologically complementary to testosterone preparations in a way that positions it as a distinct ancillary option within the iRoids Pharma catalog.

Side Effects and Health Risks

Mesterolone 10mg carries the same pharmacological side effect profile as other Mesterolone formats, with every dose-dependent consideration proportionally reduced per tablet compared to the 25mg format. These risks remain relevant at any concentration and require responsible attention.

Androgenic Effects

Mesterolone carries androgenic activity with an androgenic rating of 30 to 40. At the 10mg concentration, androgenic side effects are proportionally less pronounced per tablet than at the 25mg format. However, they remain relevant considerations. Accelerated androgenetic alopecia in genetically predisposed individuals and acne vulgaris are the most consistently reported androgenic effects with Mesterolone use. In women, virilization effects including voice deepening, clitoral enlargement, and body hair changes are serious considerations even at the conservative 10mg concentration. Women should consequently approach any androgenic compound with particular caution.

Cardiovascular Effects

Mesterolone produces adverse effects on the lipid profile including HDL cholesterol reduction and LDL cholesterol elevation associated with androgen use. At the 10mg concentration, these lipid effects are proportionally less pronounced per tablet than at the 25mg format. However, cardiovascular monitoring remains relevant for anyone using this compound regardless of the conservative concentration.

Liver Considerations

Mesterolone does not carry the hepatotoxicity associated with 17-alpha alkylated oral anabolic steroids. Its non-alkylated structure produces a fundamentally lower liver stress profile than alkylated alternatives. The 10mg concentration consequently carries the same favorable hepatotoxicity profile as the 25mg format at a proportionally lower total daily androgenic exposure per tablet. This does not eliminate the relevance of liver monitoring entirely but the hepatotoxicity risk profile remains fundamentally more favorable than alkylated alternatives at any Mesterolone concentration.

Hormonal Considerations

At standard clinical doses, Mesterolone does not significantly suppress the HPG axis or natural testosterone production. At the 10mg concentration this HPG-neutral characteristic is maintained with even greater reliability than at higher concentrations. Individual responses vary and hormonal monitoring consequently remains a responsible practice for anyone using any androgen compound.

Psychological Effects

Androgen activity carries documented associations with mood changes. These effects are generally less pronounced with Mesterolone compared to higher-potency anabolic steroids and are proportionally more subtle at the 10mg concentration than at the 25mg format. They remain a relevant consideration for anyone using this compound over extended periods.

Legal and Regulatory Status

Mesterolone is not FDA approved in the United States and is not commercially available as a prescription product in the US market. In several European countries and Asian markets, Mesterolone has historically been available as a prescription medication under the Proviron brand name produced by Bayer. Regulatory status in these markets varies and current availability and legal status should be confirmed in your specific country before purchasing.

The World Anti-Doping Agency bans Mesterolone alongside all major athletic governing bodies. It consequently appears on prohibited substance lists across Olympic sports, professional athletics, and competitive bodybuilding organizations that conduct testing.

You are responsible for confirming the legal status of Mesterolone in your specific jurisdiction before purchasing from iRoids Pharma.

Frequently Asked Questions

Is Mesterolone 10mg Available at iRoids Pharma

Yes. iRoids Pharma carries Mesterolone 10mg for customers in markets where Mesterolone is legally available. Visit iroidspharma.com to check current availability and pricing.

What Is the Half-Life of Mesterolone

Mesterolone produces a half-life of approximately 12 hours. This pharmacokinetic characteristic applies equally across the 10mg and 25mg formats and is consequently a relevant consideration for maintaining consistent plasma concentrations throughout the day regardless of which format is being used.

What Is the Practical Difference Between the 10mg and 25mg Mesterolone Formats at iRoids Pharma

Both formats contain the same active Mesterolone compound with identical pharmacological mechanisms. The 10mg format delivers 40 percent of the active compound per tablet compared to the 25mg format. The primary practical advantage of the 10mg format is dose precision, allowing total daily Mesterolone exposure to be titrated in 10mg increments rather than 25mg increments. Every dose-dependent pharmacological effect is consequently proportionally less pronounced per tablet at the 10mg concentration.

Does Mesterolone 10mg Aromatize

No. Mesterolone does not convert to estrogen at any concentration. As a DHT derivative, it is structurally incompatible with aromatase and cannot undergo enzymatic conversion to estradiol. This non-aromatizing characteristic applies equally to the 10mg and 25mg formats.

Does Mesterolone 10mg Suppress Natural Testosterone Production

At standard clinical doses, Mesterolone does not significantly suppress the HPG axis or natural testosterone production. At the 10mg concentration this HPG-neutral characteristic is maintained with even greater reliability than at higher doses due to the more conservative per-tablet androgenic exposure. Individual responses vary and hormonal monitoring consequently remains a responsible practice.

How Does Mesterolone 10mg Increase Free Testosterone

Mesterolone carries strong affinity for SHBG and displaces testosterone from SHBG binding sites, increasing the fraction of circulating testosterone that is free and biologically active. At the 10mg concentration this SHBG displacement effect is proportionally less pronounced per tablet than at the 25mg format. The mechanism itself remains pharmacologically active at any concentration however and consequently contributes to the ancillary profile of Mesterolone even at the 10mg dose.

What Are the Most Serious Health Risks at the 10mg Concentration

Androgenic effects including hair loss and acne are the most commonly reported concerns with Mesterolone at any concentration. Cardiovascular effects on lipid profiles remain relevant despite the conservative 10mg format. Virilization risk in women is a serious consideration at any androgenic compound dose. Liver toxicity is significantly lower than with 17-alpha alkylated oral steroids. All of these considerations are proportionally less pronounced per tablet at the 10mg concentration than at the 25mg format. Medical supervision is consequently recommended for anyone using this compound.

Is Mesterolone 10mg Legal to Purchase

Mesterolone is not FDA approved in the United States. It has prescription history in several European and Asian markets. Legal status varies by jurisdiction. You are consequently responsible for confirming the legal status in your jurisdiction before purchasing from iRoids Pharma.

What to Consider Before Purchasing Mesterolone 10mg

Mesterolone 10mg at iRoids Pharma represents the most precise and conservative per-tablet Mesterolone format available in our catalog. Its pharmacological profile combines moderate androgenic activity, mild aromatase inhibition, meaningful SHBG binding, low hepatotoxicity, and minimal HPG suppression through identical mechanisms to the 25mg format at proportionally reduced per-tablet exposure levels.

The 10mg format is specifically relevant for anyone researching the most conservative available entry point into Mesterolone’s multi-mechanism pharmacological profile or the most precise dose management available within the iRoids Pharma Mesterolone product range. The clinical research base accumulated during Mesterolone’s period of pharmaceutical availability across multiple international markets provides a meaningful pharmacological reference context that applies to the active compound regardless of the specific concentration format.

The iRoids Pharma non-prescription preparation does not carry the manufacturing oversight of pharmaceutical grade Proviron produced by Bayer. Manufacturing standards and quality verification consequently differ between pharmaceutical grade and non-prescription preparations. The clinical research base applies to the pharmacological and risk profile of the active compound regardless of the specific manufacturer.

Mesterolone carries documented androgenic, cardiovascular, and hormonal health considerations that require medical supervision to manage responsibly. Consulting a licensed medical professional is consequently the appropriate starting point for anyone with health concerns related to androgen use at any concentration.

For customers in markets where Mesterolone is legally available, visit iroidspharma.com to check current Mesterolone 10mg availability, pricing, and stock levels.